18f-nav4694

3 papers1 finding

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

Labs are independent when their papers share no last author and no institution.

Against: findings that point the other way from most findings on the same outcome.

On aging: the drug’s trials ARN judged to be about aging, of every trial that tests it for any use.

No results posted: trials that ended more than a year ago with no results on ClinicalTrials.gov and no paper in ARN’s record.

Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.

1 lab in 1 country

Humans3

Outcomes

Visual read sensitivity

upin humans1

1 study

18f-nav4694 improves visual read sensitivity in humans (97% vs 93%).
“Mean sensitivity at peak accuracy thresholds was higher in NAV with 97% for standard and 96% for DeepSUVR methods compared to 93% for both methods in FBP.”
Humansn = 150
The impact of AI correction on Centiloid in a same subject visual read comparison of ¹⁸ F‐Florbetapir and ¹⁸ F‐NAV4694 Aβ PET
AAIC 2025 abstract7 Jan 2026